Highlights from ASCO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
5 Jun 2020
PARP inhibitors in prostate cancer: Guidelines, who to test and the patient path...
Dr Neal Shore and Dr Elena Castro
PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway ( Dr Neal Shore and Dr Elena Castro )
5 Jun 2020
New emerging treatment options and targeted therapies for bladder cancer
Dr Arlene Siefker-Radtke and Dr Yohann Loriot
New emerging treatment options and targeted therapies for bladder cancer ( Dr Arlene Siefker-Radtke and Dr Yohann Loriot )
4 Jun 2020
EAU guidelines for treating patients with advanced prostate cancer
Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather Pay...
EAU guidelines for treating patients with advanced prostate cancer ( Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather Payne )
31 May 2020
Association of BRCA alterations with response to PARP inhibitors in metastatic c...
Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center...
Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer ( Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
30 May 2020
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progres...
Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel ( Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia )
30 May 2020
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chem...
Prof Thomas Powles - Barts Cancer Institute, London, UK
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma ( Prof Thomas Powles -  Barts Cancer Institute, London, UK )
29 May 2020
Prostate cancer patients receiving androgen-deprivation therapies shown to be at...
Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerla...
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )
7 May 2020
COVID-19: The situation in Peru and managing radiotherapy patients
Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru
COVID-19: The situation in Peru and managing radiotherapy patients ( Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru )
17 Apr 2020
Novel treatment strategies for prostate cancer: Senescence, senolytics and myelo...
Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland
Novel treatment strategies for prostate cancer: Senescence, senolytics and myeloid derived suppressor cells ( Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland )
9 Apr 2020
Shorter hormone therapy for prostate cancer
Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, C...
Shorter hormone therapy for prostate cancer ( Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, Canada )
24 Feb 2020
Micro-ultrasound for detection of clinically significant prostate cancer
Dr Davide Maffei - Humanitas University, Milan, Italy
Micro-ultrasound for detection of clinically significant prostate cancer ( Dr Davide Maffei - Humanitas University, Milan, Italy )
24 Feb 2020